Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study.

Source:http://linkedlifedata.com/resource/pubmed/id/18213621

Cancer 2008 Mar 15 112 6 1337-44

Download in:

View as

General Info

PMID
18213621